Health care pharmaceutical companies by today's price change
How far the share price has moved since the previous close.
Praxis Precision Medicines leads the 61 health care pharmaceutical companies ranked by today's price change, at +5.08%, ahead of Erasca (+2.98%) and Dianthus Therapeutics (+2.92%). Figures as of 19 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Praxis Precision Medicines+5.08%
- Median
- -0.20%
- Combined market value
- CHF 4.22T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Praxis Precision MedicinesPRAX · Health Care | +5.08% | CHF 7.6B | CHF 270.40 | 5.08% up | 86% up | ||
| 2 | ErascaERAS · Health Care | +2.98% | CHF 4.2B | CHF 11.95 | 2.98% up | 395% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | +2.92% | CHF 4.1B | CHF 72.88 | 2.92% up | 108% up | ||
| 4 | BridgeBio PharmaBBIO · Health Care | +1.67% | CHF 13B | CHF 66.87 | 1.67% up | 21% up | ||
| 5 | GenmabGMAB · Health Care | +1.28% | CHF 26.8B | CHF 43.52 | 1.28% up | 70% up | ||
| 6 | Definium TherapeuticsDFTX · Health Care | +1.27% | CHF 3.4B | CHF 24.87 | 1.27% up | 168% up | ||
| 7 | InsmedINSM · Health Care | +1.02% | CHF 22.4B | CHF 102.04 | 1.02% up | 40% down | ||
| 8 | BioMarin PharmaceuticalBMRN · Health Care | +1.00% | CHF 10.1B | CHF 52.31 | 1.00% up | 17% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | +0.99% | CHF 57.9B | CHF 18.12 | 0.99% up | 51% up | ||
| 10 | Oruka TherapeuticsORKA · Health Care | +0.87% | CHF 5.5B | CHF 81.43 | 0.87% up | 255% up | ||
| 11 | Madrigal PharmaceuticalsMDGL · Health Care | +0.86% | CHF 7.9B | CHF 338.54 | 0.86% up | 27% down | ||
| 12 | Roivant SciencesROIV · Health Care | +0.85% | CHF 23.9B | CHF 32.93 | 0.85% up | 91% up | ||
| 13 | VeradermicsMANE · Health Care | +0.84% | CHF 4.5B | CHF 106.20 | 0.84% up | 231% up | ||
| 14 | Elanco Animal HealthELAN · Health Care | +0.82% | CHF 11.3B | CHF 22.69 | 0.82% up | 26% up | ||
| 15 | Belite BioBLTE · Health Care | +0.82% | CHF 5.4B | CHF 132.80 | 0.82% up | 43% up | ||
| 16 | CytokineticsCYTK · Health Care | +0.74% | CHF 6.1B | CHF 43.59 | 0.74% up | 19% down | ||
| 17 | Cogent BiosciencesCOGT · Health Care | +0.68% | CHF 4.1B | CHF 23.61 | 0.68% up | 20% down | ||
| 18 | Axsome TherapeuticsAXSM · Health Care | +0.63% | CHF 6B | CHF 113.69 | 0.63% up | 6% down | ||
| 19 | Abbott LaboratoriesABT · Health Care | +0.62% | CHF 153.5B | CHF 88.65 | 0.62% up | 16% down | ||
| 20 | Travere TherapeuticsTVTX · Health Care | +0.45% | CHF 4.1B | CHF 42.55 | 0.45% up | 45% up | ||
| 21 | Alnylam PharmaceuticalsALNY · Health Care | +0.19% | CHF 16.9B | CHF 126.21 | 0.19% up | 66% down | ||
| 22 | Mirum PharmaceuticalsMIRM · Health Care | +0.13% | CHF 5.1B | CHF 78.09 | 0.13% up | 34% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | +0.04% | CHF 7B | CHF 107.26 | 0.04% up | 51% up | ||
| 24 | TG TherapeuticsTGTX · Health Care | +0.03% | CHF 8.4B | CHF 55.77 | 0.03% up | 117% up | ||
| 25 | Corcept TherapeuticsCORT · Health Care | -0.04% | CHF 6.3B | CHF 57.14 | 0.04% down | 10% down | ||
| 26 | ABIVAXABVX · Health Care | -0.07% | CHF 6.2B | CHF 70.64 | 0.07% down | 32% down | ||
| 27 | BeOne MedicinesONC · Health Care | -0.08% | CHF 38.8B | CHF 340.04 | 0.08% down | 16% up | ||
| 28 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | -0.10% | CHF 6.3B | CHF 80.06 | 0.10% down | 129% up | ||
| 29 | Ascendis PharmaASND · Health Care | -0.12% | CHF 14.9B | CHF 227.66 | 0.12% down | 29% up | ||
| 30 | Spyre TherapeuticsSYRE · Health Care | -0.19% | CHF 8.1B | CHF 85.39 | 0.19% down | 332% up | ||
| 31 | Arrowhead PharmaceuticalsARWR · Health Care | -0.20% | CHF 5.1B | CHF 36.28 | 0.20% down | 13% up | ||
| 32 | Royalty PharmaRPRX · Health Care | -0.23% | CHF 33.2B | CHF 57.77 | 0.23% down | 79% up | ||
| 33 | Novo NordiskNVO · Health Care | -0.25% | CHF 146.2B | CHF 33.18 | 0.25% down | 17% down | ||
| 34 | Dr. Reddy's LaboratoriesRDY · Health Care | -0.40% | CHF 10.5B | CHF 12.58 | 0.40% down | 8% up | ||
| 35 | Ionis PharmaceuticalsIONS · Health Care | -0.47% | CHF 3.8B | CHF 22.98 | 0.47% down | 63% down | ||
| 36 | AlkermesALKS · Health Care | -0.48% | CHF 6.6B | CHF 39.31 | 0.48% down | 66% up | ||
| 37 | Vertex PharmaceuticalsVRTX · Health Care | -0.53% | CHF 114.1B | CHF 449.93 | 0.53% down | 27% up | ||
| 38 | Ligand PharmaceuticalsLGND · Health Care | -0.59% | CHF 5B | CHF 250.39 | 0.59% down | 50% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | -0.59% | CHF 6.9B | CHF 99.78 | 0.59% down | 18% up | ||
| 40 | PTC TherapeuticsPTCT · Health Care | -0.71% | CHF 4.2B | CHF 50.42 | 0.71% down | 21% down | ||
| 41 | Summit TherapeuticsSMMT · Health Care | -0.86% | CHF 7B | CHF 8.78 | 0.86% down | 36% down | ||
| 42 | United TherapeuticsUTHR · Health Care | -0.87% | CHF 20.6B | CHF 482.55 | 0.87% down | 22% up | ||
| 43 | ViatrisVTRS · Health Care | -0.89% | CHF 19.4B | CHF 16.95 | 0.89% down | 99% up | ||
| 44 | Legend BiotechLEGN · Health Care | -0.92% | CHF 2.6B | CHF 13.58 | 0.92% down | 41% down | ||
| 45 | Jazz PharmaceuticalsJAZZ · Health Care | -1.06% | CHF 13.3B | CHF 206.69 | 1.06% down | 41% up | ||
| 46 | Amneal PharmaceuticalsAMRX · Health Care | -1.10% | CHF 6.4B | CHF 18.25 | 1.10% down | 90% up | ||
| 47 | PfizerPFE · Health Care | -1.12% | CHF 133.3B | CHF 23.39 | 1.12% down | 15% up | ||
| 48 | Regeneron PharmaceuticalsREGN · Health Care | -1.13% | CHF 81.5B | CHF 788.25 | 1.13% down | 28% up | ||
| 49 | Eli LillyLLY · Health Care | -1.13% | CHF 1.03T | CHF 1,152.34 | 1.13% down | 33% up | ||
| 50 | GSKGSK · Health Care | -1.17% | CHF 81.1B | CHF 40.48 | 1.17% down | 5% up | ||
| 51 | AbbVieABBV · Health Care | -1.27% | CHF 420.8B | CHF 238.04 | 1.27% down | 25% up | ||
| 52 | AstraZenecaAZN · Health Care | -1.39% | CHF 230.5B | CHF 148.63 | 1.39% down | 1% up | ||
| 53 | Edgewise TherapeuticsEWTX · Health Care | -1.50% | CHF 3.8B | CHF 34.36 | 1.50% down | 86% up | ||
| 54 | GrifolsGRFS · Health Care | -1.53% | CHF 4.8B | CHF 7.03 | 1.53% down | 0% up | ||
| 55 | Bristol-Myers SquibbBMY · Health Care | -1.65% | CHF 101B | CHF 49.39 | 1.65% down | 30% up | ||
| 56 | Merck & CoMRK · Health Care | -1.79% | CHF 281.2B | CHF 114.06 | 1.79% down | 45% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | -1.84% | CHF 543.3B | CHF 225.71 | 1.84% down | 34% up | ||
| 58 | SanofiSNY · Health Care | -2.16% | CHF 93.3B | CHF 38.87 | 2.16% down | 4% down | ||
| 59 | NovartisNVS · Health Care | -2.29% | CHF 241.6B | CHF 127.91 | 2.29% down | 25% up | ||
| 60 | ZoetisZTS · Health Care | -2.72% | CHF 28.5B | CHF 70.19 | 2.72% down | 26% down | ||
| 61 | Teva Pharmaceutical IndustriesTEVA · Health Care | -3.23% | CHF 40.2B | CHF 34.44 | 3.23% down | 74% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8432 CHF).
Questions and answers
Which health care pharmaceutical companies rank first by today's price change?
Praxis Precision Medicines (+5.08%), Erasca (+2.98%) and Dianthus Therapeutics (+2.92%) are the top three of the 61 health care pharmaceutical companies ranked by today's price change as of 19 Nov 2026, 14:43 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by today's price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by today's price change have a combined market value of CHF 4.22T as of 19 Nov 2026, 14:43 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by today's price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.